CD28 and non-small cell lung carcinoma: To test the idea that NSCLC drives AMPKhigh and mal-differentiation of T cells through CD39-containing exosomes, NSCLC-derived exosomes were used for T cell pre-incubation, followed by T cell activation with anti-CD3/CD28 beads.